Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More
Coronavirus-Related News from UC San Diego Health
Features Howard Taras, MD, and Kimberly Brouwer, PhD
The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthe ...
Features Christopher Longhurst, MD, CIO, ACMO
Features Sandra Leibel, MD
Features Edward Cachay, MD
Features Christopher Longhurst, MD, CIO, ACMO, and Patty Maysent, CEO
Features Alessandro Sette, PhD, and Shane Crotty, PhD
Features Rob Knight, PhD
Features David Pride, MD, PhD
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intende ...
During the COVID-19 pandemic, Moores Cancer Center at UC San Diego Health continues to offer potentially lifesaving treatment through cancer clinical trials.
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COV ...
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
During COVID-19, UC San Diego Health expanded telehealth to provide patients with safe and convenient access to appointments with their health care providers. Video visits expanded by more than 50-fol ...
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites ...
Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.